Expanded fertility services (ART/IVF/AI) — Coverage and medical necessity
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines coverage, medical criteria, and prior authorization rules for expanded fertility benefits (assisted reproductive technologies, AI, IVF, donor gametes, fertility preservation) for members with the purchaser's Expanded Fertility Benefit Coverage.
Text Revised Effective 4/1/2025 to add or update case rate codes S4020 and S4021 for IVF procedure cancellations and other case-rate labeling.
Coverage criteria and clinical policy
Definition and diagnostic pathways for AFAB infertility
Infertility is defined for members assigned female at birth (AFAB) when ALL of the following apply OR alternative pathways are met:
Include time attempted to conceive prior to any pregnancy (e.g., prior miscarriage) in the calculation.
Requests where prior sterilization may relate to current inability to conceive will undergo clinician review (administrative exclusion may apply).
Amenorrhea and elevated FSH after age 42 is considered equivalent to normal menopause (excluded).
Costs for medications, professional, technical and facility charges related to these three AI cycles are covered; donor sperm procurement/processing/storage not covered until infertility diagnosis is established; home AI is not covered.
Examples are illustrative, not exhaustive; supporting diagnostic documentation should be provided.
AI (ICI and IUI)
Artificial Insemination (AI) cycles:
Applies to both ICI and IUI.
IVF: SET, Reciprocal IVF, and MET criteria
IVF-related coverage and medical necessity rules:
If the cycle is beyond 4 IVF cycles, additional criteria apply as specified under 'After 4 In Vitro Fertilization (IVF) Cycles.'
If the cycle is beyond 4 IVF cycles, additional criteria apply.
If the cycle is beyond 4 IVF cycles, additional criteria apply.
After 4 IVF cycles
Criteria for continued IVF services after 4 cycles:
Used by the insurer to determine approval of further transfers; each embryo transfer (fresh or frozen) counts as one cycle.
Single Embryo Transfer (SET) and Reciprocal IVF
Covered when ALL of the following are met
Authorization is for cycle tracking only; see post‑4 cycle rules if applicable.
Multiple Embryo Transfer (MET)
Multiple Embryo Transfer (MET) coverage stance
Refer to the MET criteria list for exact age and prior-cycle conditions.
Claims may be denied if MET is performed without meeting the documented medical necessity criteria.
Continuation of IVF after 4 cycles
Continued IVF after four consecutive failed cycles
Each embryo transfer (fresh or frozen) counts as one cycle.
Requesting physician must submit the documentation and revised methodology with literature-supported predicted success rate and member consent for further transfers.
Covered services
Covered services and conditions
If the member was billed directly, the member must submit the applicable reimbursement form for payment.
Claims for multiyear storage (storage over 12 months) are not covered; coverage may vary by group/contract.
Definitions and clinical criteria for AMAB infertility are provided elsewhere in the policy.
Exclusions / Not covered
Noncovered services and contractual exclusions
Claims for donor egg cycles should include documentation that the member meets the infertility definition if coverage is claimed.
Procurement/processing/storage of donor sperm is not covered until infertility diagnosis is established.
Administrative denials for contractual exclusion are distinct from medical necessity determinations.
Premature ovarian failure under age 43 is an exception to this exclusion.
Procedures with evidentiary determinations
Procedures with evidence-based stance
EmbryoGlue (CPT 89398) is considered not medically necessary per policy.
Policy notes limited benefit for live birth outcomes.
Blastocyst transfer is supported for improving live birth rates.
Embryo co-culture is considered unproven and not supported by the literature reviewed.
Embryo Co-Culture — Evidence Summary
Evidence and coverage stance regarding embryo co-culture
Updated literature reviews did not identify studies to change this conclusion; co-culture is not supported.
Intracytoplasmic Sperm Injection (ICSI)
ICSI clinical stance
ASRM/SART guidance: ICSI does not improve outcomes for unexplained infertility or advanced maternal age but is safe and effective for indicated uses.
Single Embryo Transfer (SET) supportive evidence
Clinical rationale and observed outcomes supporting SET
Findings support SET to improve perinatal outcomes for appropriately selected patients.
Covered procedures — case-rate codes
Coverage enumerates specific case-rate procedure codes for IVF and related procedures.
No additional clinical eligibility criteria are provided in the code listing fragments; proper code selection and billing rules apply.
Code listings (no coverage criteria)
Coding and case-rate assignments for IVF and related procedures as listed
The chunks present code descriptors and case-rate labeling; clinical coverage criteria are addressed elsewhere in the policy.
Services covered without infertility diagnosis
Covered without diagnosis of infertility
Providers do not need to document infertility for these codes; submit appropriate claims per benefit rules.
Infertility-required services
Covered only when member meets the policy definition of infertility
Claims for these codes should be accompanied by documentation meeting the policy infertility definition.
Fertility preservation and related services
Covered for members who meet infertility definition or are undergoing elective fertility preservation
Documentation should indicate whether coverage is claimed for infertility or for elective fertility preservation (elective preservation has separate lifetime limits for certain services).
Coverage categories by clinical status/intent
Coverage organized by member clinical status and service intent
See code list for exact codes.
Claims lacking qualifying documentation risk denial.
Elective fertility preservation has a lifetime limit of up to 3 egg/oocyte retrieval cycles; submit primary diagnosis Z31.84 for elective preservation claims.
Examples include multiple semen analysis CPTs and tubal surgery codes listed in the diagnostic section.
Home artificial insemination (ICI/IUI) is not covered. The policy also notes that the costs of medications, professional, technical and facility charges for the three (3) AI (ICI or IUI) cyclesdonor sperm procurement, processing and storage will not be covered until a diagnosis of infertility has been established.
EmbryoGlue (hyaluronic acid–enriched transfer medium; CPT 89398) and the Hyaluronan Binding Assay for sperm evaluation are both identified in the policy as not medically necessary due to insufficient evidence demonstrating improved net health outcomes. These modalities should not be submitted as medically necessary services under the infertility benefit.
Donor gamete coverage is conditional: donor eggs are not covered for AFAB members who do not meet the policy's Definition of Infertility. Likewise, donor sperm are not covered when provided for members (AFAB or AMAB) who do not meet the Definition of Infertility, and donor sperm for AMAB members who previously underwent sterilization is also not covered. Agency fees or donor‑transportation charges from egg donation facilitation agencies are explicitly not covered.
The policy treats embryo co‑culture as an unproven laboratory technique: no standardized co‑culture method has emerged and no controlled trials have demonstrated improved implantation or pregnancy rates. Updated literature reviews did not identify evidence that would change this conclusion, and co‑culture remains unsupported as medically necessary.
All services related to a surrogate (gestational or otherwise) are excluded from coverage when the surrogate is not a member of this plan. Providers should distinguish surrogate arrangements from Reciprocal IVF (which involves members who are both in‑plan) when determining coverage.
Portions of the document present coding and case‑rate listings (including CPT and S‑codes such as 58970, 89280–89281, S4011–S4018) without accompanying clinical coverage criteria in those fragments. These sections are intended as coding descriptors and case‑rate labels rather than standalone medical necessity statements.
In several fragments the policy does not present explicit exclusions beyond the coding distinctions; instead, coverage is organized by clinical status and intent into groups: codes covered without a diagnosis of infertility, codes covered only when the member meets the policy definition of infertility, and codes covered for members who meet infertility definition or are undergoing elective fertility preservation.
The coding fragments cited elsewhere in the document contain no explicit exclusion language in those specific excerpts; they focus on case‑rate code enumerations and descriptors rather than exclusionary statements. Refer to the policy exclusions sections for non‑covered services.
Coverage distinctions are largely organized by code group: certain procedures (e.g., IUI/ICI, sperm processing codes) are covered without an infertility diagnosis, a separate group of procedures (including donor cycles and certain cryopreservation/retrieval services) are covered only when the member meets the policy definition of infertility, and many cryopreservation, storage and related services are covered either for infertility or elective fertility preservation. Providers must document infertility status or elective preservation intent as applicable.
The policy explicitly lists several codes as non‑covered, including 55400 (vasovasostomy/vasovasorrhaphy) and the listed cytogenetic codes 88240 and 88241. Claims for those codes should be adjudicated as not covered per the policy's non‑covered codes list.
Multiple Embryo Transfer (MET) is considered not medically necessary when the specified medical criteria are not met. MET does not require an infertility diagnosis but is medically necessary only if one of the enumerated criteria (age, diminished reserve, prior SET failures, donor‑egg specific conditions, or age ≥38) is satisfied; MET without meeting any listed criteria will not meet medical necessity.
This reiterates that both EmbryoGlue (CPT 89398) and the Hyaluronan Binding Assay are judged not medically necessary in the policy due to insufficient evidence of benefit and therefore should not be billed as medically necessary infertility treatments.
Assisted hatching and embryo co‑culture are discussed as procedures with evidence limitations: assisted hatching has not been shown in RCTs and meta‑analyses to increase live birth rates (though some analyses show improved clinical pregnancy rates), and embryo co‑culture lacks controlled‑trial evidence and no standardized method has emerged, supporting a cautious or non‑coverage stance for co‑culture.
The policy makes a clear evidence‑based statement that embryo co‑culture is not supported by controlled trials demonstrating improved implantation or pregnancy rates and that no standardized co‑culture technique has been established; therefore co‑culture is not considered supported by the available literature.
The coding excerpted in some parts of the document (for example the microtechnique and oocyte lab procedure listings) does not include explicit not‑medically‑necessary statements within those fragments; NMN determinations for specific codes are presented elsewhere in the policy's clinical sections.
Similarly, portions of the document that list S‑codes and case‑rate descriptors (including S4013–S4020 and CPT 58970) do not themselves contain 'not medically necessary' language within the fragment; NMN conclusions for procedures such as EmbryoGlue or Hyaluronan assays are located in the coverage/exclusion sections.
Across the policy fragments, the explicit 'not medically necessary' determinations are present for EmbryoGlue and the Hyaluronan Binding Assay, and the evidence‑based non‑support for embryo co‑culture is stated; other coding fragments do not restate NMN findings within their code‑listing text.
Billing codes, groups, and limits
| Z31.84 | Encounter for fertility preservation procedure |
| 58970 | Egg retrieval / related covered procedure (listed as covered; no prior auth required) |
| Z31.84 | Encounter for fertility preservation procedure (to be submitted as primary diagnosis for elective fertility preservation) |
| 58974 | Embryo transfer, intrauterine |
| 58976 | Gamete, zygote or embryo intrafallopian transfer, any method |
| 76948 | Ultrasonic guidance for aspiration of ova, imaging supervision and interpretation |
| 89250 | Culture of oocyte(s)/embryo(s), less than 4 days |
| 89251 | Culture of oocyte(s)/embryo(s), less than 4 days; with co-culture |
| 89253 | Assisted embryo hatching, microtechniques (any method) |
| 89254 | Oocyte identification from follicular fluid |
| 89280 | Assisted oocyte fertilization, microtechnique; less than or equal to 10 oocytes |
| 89281 | Assisted oocyte fertilization, microtechnique; greater than 10 oocytes |
| S4011 | In vitro fertilization; including identification and incubation of mature oocytes, fertilization, incubation of embryos, and visualization |
| S4011 | In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development |
| S4013 | Complete cycle, gamete intrafallopian transfer (GIFT), case rate |
| S4014 | Complete cycle, zygote intrafallopian transfer (ZIFT), case rate |
| S4015 | Complete in vitro fertilization cycle, not otherwise specified, case rate |
| S4016 | Frozen in vitro fertilization cycle, case rate |
| S4011 | In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development |
| S4013 | Complete cycle, gamete intrafallopian transfer (GIFT), case rate |
| S4014 | Complete cycle, zygote intrafallopian transfer (ZIFT), case rate |
| S4015 | Complete in vitro fertilization cycle, not otherwise specified, case rate |
| S4016 | Frozen in vitro fertilization cycle, case rate |
| S4017 | Incomplete cycle, treatment cancelled prior to stimulation, case rate |
| S4018 | Frozen embryo transfer procedure cancelled before transfer, case rate (NSR) |
| 89281 | Referenced diagnostic/procedural code in association with IVF cycle descriptions |
| 58970 | Procedure code referenced (appears at top of section) |
| S4013 | Complete cycle — case rate (GIFT) |
| S4014 | Complete cycle, gamete intrafallopian transfer (ZIFT), case rate |
| S4015 | Complete in vitro fertilization cycle, not otherwise specified, case rate |
| S4016 | Frozen in vitro fertilization cycle, case rate |
| S4017 | Incomplete cycle, treatment cancelled prior to stimulation, case rate |
| S4018 | Frozen embryo transfer procedure cancelled before transfer, case rate |
| S4020 | In vitro fertilization procedure cancelled before aspiration, case rate (NSR) / Frozen embryo transfer procedure cancelled before transfer, case rate (NSR) |
| S4013 | Complete cycle, gamete intrafallopian transfer (GIFT) / case rate |
| S4014 | Complete cycle, zygote intrafallopian transfer (ZIFT) / case rate |
| S4015 | Complete in vitro fertilization cycle, not otherwise specified / case rate |
| S4016 | Frozen in vitro fertilization cycle / case rate |
| S4017 | Incomplete cycle, treatment cancelled prior to stimulation / case rate |
| S4018 | Frozen embryo transfer procedure cancelled before transfer / case rate (NSR) |
| S4020 | In vitro fertilization procedure cancelled before aspiration / case rate (Text Revised Effective 4/1/2025) |
| S4021 | In vitro fertilization procedure cancelled after aspiration / case rate (Text Revised Effective 4/1/2025) |
| 58321 | Artificial insemination; intra-cervical |
| 58322 | Artificial insemination; intra-uterine |
| 58323 | Sperm washing for artificial insemination |
| 89260 | Sperm isolation; simple prep (e.g., sperm wash and swim-up) for insemination or diagnosis with semen analysis |
| 89261 | Sperm isolation; complex prep (e.g., Percoll gradient, albumin gradient) for insemination or diagnosis with semen analysis |
| S4035 | Stimulated intrauterine insemination (IUI), case rate |
| 55870 | Electroejaculation |
| 89264 | Sperm identification from testis tissue, fresh or cryopreserved |
| 89335 | Cryopreservation, reproductive tissue, testicular |
| 89344 | Storage (per year); reproductive tissue, testicular/ovarian |
| 89354 | Thawing of cryopreserved; reproductive tissue; testicular/ovarian |
| S4023 | Donor egg cycle, incomplete, case rate |
| S4025 | Donor services for in vitro fertilization (sperm or embryo), case rate |
| S4026 | Procurement of donor sperm from sperm bank |
| S4028 | Microsurgical epididymal sperm aspiration (MESA) |
| 89257 | Sperm identification from aspiration (other than seminal fluid) |
| 89258 | Cryopreservation; embryo(s) |
| 89259 | Cryopreservation; sperm |
| 89337 | Cryopreservation, mature oocyte(s) |
| 89342 | Storage (per year); embryo(s) |
| 89343 | Storage (per year); sperm/semen |
| 89346 | Storage (per year); oocyte |
| 89356 | Thawing of cryopreserved; oocytes, each aliquot |
| S3655 | Antisperm antibodies test (immunobead) |
| S4027 | Storage of previously frozen embryos |
| 58321 | Artificial insemination; intra-cervical |
| 58322 | Artificial insemination; intra-uterine |
| 58323 | Sperm washing for artificial insemination |
| 89260 | Sperm isolation; simple prep (e.g., sperm wash and swim-up) for insemination or diagnosis with semen analysis |
| 89261 | Sperm isolation; complex prep (e.g., Percoll gradient, albumin gradient) for insemination or diagnosis with semen analysis |
| S4035 | Stimulated intrauterine insemination (IUI), case rate |
| 55870 | Electroejaculation |
| 89264 | Sperm identification from testis tissue, fresh or cryopreserved |
| 89335 | Cryopreservation, reproductive tissue, testicular |
| 89344 | Storage (per year); reproductive tissue, testicular/ovarian |
| 89354 | Thawing of cryopreserved; reproductive tissue; testicular/ovarian |
| S4023 | Donor egg cycle, incomplete, case rate |
| S4025 | Donor services for in vitro fertilization (sperm or embryo), case rate |
| S4026 | Procurement of donor sperm from sperm bank |
| S4028 | Microsurgical epididymal sperm aspiration (MESA) |
| 89257 | Sperm identification from aspiration (other than seminal fluid) |
| 89258 | Cryopreservation; embryo(s) |
| 89259 | Cryopreservation; sperm |
| 89337 | Cryopreservation, mature oocyte(s) |
| 89342 | Storage (per year); embryo(s) |
| 89343 | Storage (per year); sperm/semen |
| 89346 | Storage (per year); oocyte |
| 89356 | Thawing of cryopreserved; oocytes, each aliquot |
| S3655 | Antisperm antibodies test (immunobead) |
| S4027 | Storage of previously frozen embryos |
| 55200 | Vasotomy, cannulization with or without incision of Vas, unilateral or bilateral |
| 58350 | Chromotubation of oviduct, including materials |
| 58750 | Tubotubal anastomosis |
| 89300 | Semen analysis; presence and/or motility of sperm including Huhner test (post coital) |
| 89310 | Semen analysis; motility and count (not including Huhner test) |
| 89320 | Semen analysis; complete (volume, count, motility and differential) |
| 89321 | Semen analysis, presence and/or motility of sperm |
| 89322 | Semen analysis: volume, count, and differential using strict morphologic criteria (e.g.,Kruger) |
| 89325 | Sperm antibodies |
| 89329 | Sperm evaluation; hamster penetration test |
| 89398 | Unlisted reproductive medicine laboratory procedure |
Authorization, documentation, and billing actions for providers
Prior authorization required for SET, reciprocal IVF, MET, and post‑4 cycles
Prior authorization is required for in vitro fertilization cycles with Single Embryo Transfer (SET) and for reciprocal IVF; authorization is for cycle tracking and does not require meeting a diagnosis of infertility for initial cycles. Prior authorization is also required for Multiple Embryo Transfer (MET) and for any IVF cycle after four prior IVF cycles that did not result in pregnancy and delivery (prior authorization is recommended for Commercial Products).
- SET and reciprocal IVF: prior authorization required for cycle tracking even when no infertility diagnosis is present (initial cycles).
- MET and any cycle after 4 IVF cycles: prior authorization recommended for Commercial Products; lack of prior authorization may lead to non-coverage.
Prior authorization recommended for SET/MET and post‑4 cycles (Commercial Products)
The policy recommends prior authorization for SET (for cycle tracking), MET cycles, and any cycle after four IVF cycles that did not result in pregnancy and delivery; AI (ICI or IUI) cycles do not require prior authorization when AI only is rendered.
- No prior authorization is needed when only AI (ICI or IUI) is rendered.
- Prior authorization is recommended for SET (cycle tracking), MET, and post‑4th IVF cycles for Commercial Products.
Storage and shipping: coverage limits and reimbursement
Storage and monitoring codes for cryopreserved cells are covered up to one year (12 months) per benefit year; cell shipping reimbursement is covered at 100% up to a $1,000 lifetime maximum per member. Claims for multiyear storage (over 12 months) are not covered.
Count each embryo transfer as one IVF cycle for authorization/adjudication
For cycle-counting and adjudication, each embryo transfer procedure (whether single or multiple, fresh or frozen) is counted as one IVF cycle; if pregnancy is not achieved, a new cycle begins with the next embryo transfer.
- Each embryo transfer (single or multiple; fresh or frozen) = 1 cycle for cycle limits.
- Cycle counting affects prior authorization and continuation review after four cycles.
Claims note: 58970 covered; use Z31.84 for elective fertility preservation
Code 58970 is listed as covered with no prior authorization required. For elective fertility preservation (limited to 3 cycles per lifetime), submit primary diagnosis Z31.84 to ensure correct claims processing and coordination of benefits.
- 58970 is covered and no prior authorization is required.
- When services are for elective fertility preservation, claims must be submitted with primary diagnosis Z31.84 (limited to 3 cycles lifetime).
IVF case‑rate/package codes listed (S4011, S4013–S4018; S4020/S4021 added)
The document enumerates case-rate (package) codes for complete, frozen, incomplete, and cancelled IVF-related cycles (S4011, S4013–S4018, with additional S4020/S4021 entries added effective 4/1/2025). The fragment lists these codes but does not state specific prior authorization requirements in these chunks.
Procedure and case‑rate code listings (S4011–S4018, 89281)
The policy lists specific procedure and case-rate codes associated with IVF and related procedures (S4011–S4018 and 89281 are referenced in this fragment); no explicit prior authorization language appears within these code-listing chunks.
- Referenced codes in the fragment include S4011–S4018 and CPT 89281 alongside assisted oocyte fertilization codes.
- The excerpt functions as a coding listing; prior authorization rules are not specified here.
Code enumeration present without explicit prior authorization language
This section lists case-rate and procedure S-codes (S4013–S4018, S4020, S4021) and CPT 58970; the chunks contain code enumeration but do not include explicit prior authorization requirement language.
- S4013–S4018 and S4020 are enumerated with Effective 4/1/2025 references.
- No explicit prior authorization wording is present in these code-list chunks.
IVF case‑rate codes enumerated; follow billing rules and related prior authorization policy
Multiple IVF-related case-rate codes (S4013–S4018, S4020, S4021) are enumerated and labeled with an effective date revision; the policy notes that correct case-rate selection and prior authorization are required per billing rules, and refers to related payer guidance for applicable prior authorization procedures.
See payer's Prior Authorization policy for applicable requirements
Refer to the payer's 'Prior Authorization of Services, Treatments or Procedures' policy for applicable prior authorization requirements and processes that apply to services described here.
- This document references a separate Prior Authorization policy that governs authorization procedures.
- Providers should consult that related policy for specifics on how to request authorization.
Three AI cycles by a specialist establish infertility (AFAB without sperm exposure)
For AFAB members without exposure to sperm, infertility is established only after three consecutive AI cycles (ICI or IUI) performed by a qualified specialist; costs for medications, professional, technical and facility charges related to these three AI cycles are covered, but donor sperm procurement/processing/storage and home AI are not covered until infertility is established.
- Infertility is determined after 3 consecutive AI (ICI or IUI) cycles for AFAB members without sperm exposure.
- Costs associated with those three AI cycles are covered; donor sperm procurement/processing/storage not covered until diagnosis established; home AI (ICI/IUI) is not covered.
Documentation and review required to continue IVF after 4 failed cycles
Continuation of IVF services after four consecutive IVF cycles that did not result in pregnancy and delivery is considered medically necessary only when the requesting physician provides required documentation (number/type of past IVF/AI attempts, revised IVF methodology with literature-supported predicted success rate, and member informed consent); otherwise continuation is not medically necessary.
- Required physician submission for post‑4 cycles: documentation of number/type of past IVF/AI attempts; details of revised IVF methodology and predicted success rate supported by literature; documentation that the member accepts the predicted success rate.
- If these criteria are not met, continuation after 4 cycles is considered not medically necessary.
No explicit provider actions in this fragment
No provider actions are recorded in these inventory notes (empty inventory).
No step therapy directives specified
No step therapy directives are specified in this section of the policy.
- The policy explicitly states that no step therapy directives are specified in this section.
No explicit provider actions in this fragment
No explicit provider actions are listed in this inventory fragment (empty inventory).
No explicit provider actions in this fragment
No explicit provider actions are listed in this inventory fragment (empty inventory).
No step therapy or sequencing requirements specified
No step therapy requirements are described in these excerpts of the policy.
- The document contains coding and case-rate listings without step therapy or sequencing requirements.
No step therapy requirements in this excerpt
No step therapy directives or sequencing requirements are present in this excerpt.
- The policy text in these chunks focuses on code enumeration and does not impose step therapy.
Physician must document prior attempts, revised methodology, and member consent for post‑4 cycles
For requests after four IVF cycles that did not result in pregnancy and delivery, the requesting physician must submit: documentation of number and type of all past IVF/AI attempts; details of a revised IVF methodology with a predicted success rate supported by literature; and documentation that the member has been informed of and accepts the predicted success rate.
- Physician must include prior attempt history, revised methodology with literature support, and member consent/acknowledgement of predicted success rate.
Authorization required for SET and reciprocal IVF (cycle tracking)
Prior authorization is required for Single Embryo Transfer (SET) and reciprocal IVF for cycle tracking even when no medical criteria or infertility diagnosis is required for initial cycles.
- Authorization is for cycle tracking purposes only for initial SET and reciprocal IVF cycles.
- If cycles exceed four, additional medical criteria and documentation apply.
Required documentation for continuation after 4 IVF cycles
For requests to continue IVF after four cycles, the requesting physician must provide documentation of number/type of prior IVF/AI attempts, a revised IVF methodology with a literature‑supported predicted success rate, and documentation that the member was informed of and accepts the predicted success rate.
- These documentation items are used to determine approval of further transfer procedures after 4 failed cycles.
Member must submit reimbursement form if billed directly for shipping/storage
If the member was billed directly for cell shipping or storage, the member must submit the applicable Cell Shipping or Cell Storage Reimbursement Form to request reimbursement; forms are provided by the payer.
- Member-submitted claims require use of the provided Cell Shipping Reimbursement Form or Cell Storage Reimbursement Form (links in policy).
Document embryo transfer event to establish IVF cycle boundaries
Document the embryo transfer event (fresh or frozen) as the start/end of an IVF cycle for adjudication and for coordination with sperm retrievals or related procedures.
- Each embryo transfer marks the start/end of a cycle; documentation supports cycle counting and adjudication.
Use diagnosis Z31.84 for elective fertility preservation claims (3‑cycle lifetime limit)
For elective fertility preservation (limited to three cycles per lifetime), claims must be submitted with primary diagnosis Z31.84 to ensure correct claims processing and coordination of benefits; Z31.84 should not be used for members who meet the definition of infertility.
- Elective preservation is limited to 3 retrieval cycles per lifetime; use Z31.84 as the primary diagnosis for such claims.
- Do not use Z31.84 for members meeting the infertility definition (those have no lifetime cycle limits).
No explicit provider actions in this fragment
No explicit provider actions are listed in this inventory fragment (empty inventory).
Procedure/case‑rate codes listed (coding fragment only)
The document lists procedure and case-rate codes (S4011–S4018 and related S-codes) and references CPT 89281 in association with IVF procedures; these chunks are code listings and do not specify prior authorization language.
- S4011–S4018 and 89281 appear in the coding fragments as descriptors for IVF-related services.
- These are coding listings without PA instructions in these chunks.
S-code enumeration and CPT reference (no PA language here)
This S-code enumeration and CPT references section lists S4013–S4020 and CPT 58970 in relation to IVF/GIFT/ZIFT cycles and cancelled procedures; no explicit prior authorization text is present in these chunks.
- S4013–S4020 are enumerated with descriptors for complete, frozen, incomplete, and cancelled cycles.
- CPT 58970 is referenced alongside these S-codes.
Document infertility status or elective fertility preservation intent on claims
Providers must document the member's infertility status or indicate elective fertility preservation intent, because coverage of certain codes differs depending on whether the member meets the definition of infertility or is undergoing elective preservation.
- Some codes are covered without an infertility diagnosis, while others are covered only when the member meets the infertility definition or is undergoing elective preservation—providers must document the member's status accordingly.
Verify benefits and eligibility with the payer before providing services
Providers should verify member-specific benefits and eligibility with the provider call center; benefits and eligibility are determined by the member's subscriber agreement or employer agreement, which supersede this medical policy.
- Contact the provider call center for member-specific benefit/eligibility questions before proceeding with services.
Failure to submit required post‑4 cycles documentation risks denial
After four IVF cycles that do not result in pregnancy and delivery, further transfer procedures require physician submission of documentation for review (number/type of prior attempts; revised methodology with literature‑supported predicted success rate; and member informed acceptance); failure to provide required documentation may lead to denial of additional transfers.
- Lack of the required post‑4 cycles documentation may result in denial of requests for further transfer procedures.
Not obtaining recommended prior authorization for MET or post‑4 cycles may cause denial
Lack of prior authorization (or failure to follow recommended prior authorization practices) for MET cycles or for cycles after four IVF cycles that did not result in pregnancy and delivery may result in non-coverage or claim denial; prior authorization is recommended for Commercial Products in these cases.
- Providers are advised to obtain prior authorization for MET and post‑4th IVF cycles to reduce risk of claim denial.
Previous sterilization may trigger administrative exclusion and denial
Requests for fertility services for a member who has undergone a previous sterilization procedure will undergo clinician review; if inability to conceive may be related to prior sterilization, an administrative denial may result (this is not a medical necessity review).
- Providers should be prepared for administrative review and possible denial when prior sterilization may explain infertility.
Donor eggs/sperm provided without infertility diagnosis risk noncoverage
Donor eggs and donor sperm are not covered when provided for members who do not meet the Definition of Infertility (donor sperm is also not covered for AMAB members with prior sterilization); use of donor material without meeting infertility criteria can trigger noncoverage.
- Donor eggs not covered for AFAB members who do not meet the infertility definition.
- Donor sperm not covered for AFAB or AMAB members who do not meet infertility definition, or for AMAB members with prior sterilization.
Incorrect cycle counting can affect benefit adjudication
Each embryo transfer is counted as one cycle for benefit adjudication; not adhering to the policy's cycle counting rules may affect benefit determination and prior authorization outcomes.
- Document transfers accurately because cycle counting impacts eligibility for continued services after four cycles.
Surrogate-related services excluded when surrogate is not plan member
Claims for services related to surrogate parents are excluded from coverage when the surrogate is not a member of this plan; providers should not expect coverage for surrogate-related services in those cases.
- All services related to surrogates are excluded when the surrogate is not a member of the plan.
Coding listing only — no explicit authorization/denial triggers in this fragment
This excerpt is principally a listing of procedure and case‑rate codes and does not contain explicit authorization or denial trigger language; providers should refer to other policy sections for actionable prior authorization rules.
- Code-listing fragments do not substitute for authorization guidance—consult the Prior Authorization policy or the coverage criteria sections.
Case‑rate code listing without PA/denial language
This coding fragment enumerates case‑rate/IVF codes but contains no explicit prior authorization or denial triggers; providers must consult coverage criteria and the Prior Authorization policy for authorization requirements.
- Code listings alone do not define authorization requirements.
No explicit denial or PA rules in these code fragments
No denial triggers or prior authorization rules are stated in these chunks; they are code‑focused fragments and do not replace the policy sections that define authorization and denial conditions.
- Providers should use the main coverage criteria and Prior Authorization policy to determine actionable requirements.
Some codes are covered only when member meets infertility definition — document accordingly
Coverage of certain codes (for example, 89335, 89344, 89354, S4023, S4025, S4026, S4028) is limited to members who meet the policy definition of infertility; claims lacking documentation that the member meets the infertility definition risk denial.
- Ensure documentation demonstrates the member meets the policy's infertility definition when submitting claims for these codes.
Definitions and terms used in this policy
Clinical background and evidence summary
Background: Assisted reproductive technologies (ART) encompass procedures where eggs or embryos are handled, including in‑vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), microtechniques (e.g., assisted oocyte fertilization CPT 89280/89281), and case‑rate S‑codes (S4011–S4018). The policy differentiates coverage by clinical indication, cycle counting, and bundled/case‑rate code assignments.
Intracytoplasmic sperm injection (ICSI) is supported for appropriate indications—principally male‑factor infertility such as low sperm count, abnormal morphology or poor motility—and has high fertilization and competitive pregnancy rates reported in series. The policy notes that ICSI is considered safe and effective for indicated uses (including use with testicular/epididymal sperm retrieval techniques) but that ICSI has not been shown to improve outcomes for unexplained infertility or advanced maternal age when not otherwise indicated.
Single Embryo Transfer (SET) is supported by registry data showing reduced multiple gestation risk and improved good perinatal outcomes compared with other embryo transfer strategies (for example, elective single ET had a good perinatal outcome of 37.1% versus 18.9% for other ETs in the cited series). The policy uses this evidence to support SET as a preferred approach where clinically appropriate and notes prior authorization is required for SET cycles for cycle‑tracking purposes.
Policy revisions and effective dates
Text revised to add or update IVF case-rate codes S4020 (procedure cancelled before aspiration) and S4021 (procedure cancelled after aspiration) and related case-rate labeling, effective 4/1/2025.
The document includes a procedural coding update that is labeled Effective 4/1/2025 in the case‑rate code listings (addition or update of codes such as S4020 and S4021 related to cancelled IVF procedures and case‑rate labeling). Providers should be aware of the Effective 4/1/2025 text revision when selecting case‑rate codes for billing.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.